ORCL vs STRO · P/E 31, rev $67.36B vs rev $62.0M
Oracle Corporation (ORCL) versus Sutro Biopharma (STRO) — a side-by-side from cached financials, not a winner call.
Oracle Corporation (ORCL) is a software - infrastructure company listed on NYSE. It is led by Safra Catz.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
Latest reported ORCL revenue for 2026-05-31 was $67.36B. Net income was $17.09B. Revenue was up 17.3% from 2025-05-31 to 2026-05-31. ORCL currently screens at market cap $527.84B and trailing P/E 31.4.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
ORCL currently screens at market cap $527.84B and trailing P/E 31.4. STRO currently screens at market cap $470.8M.
Not investment advice. Open the ORCL and STRO stock pages for the full models.
Not investment advice.